Registered entities
Rempex Pharmaceuticals, Inc.
Reg. No. 275026000United States
Innovation
36 patent families (20 granted) — focus: Human necessities, Chemistry & metallurgy, Operations & transport; filing pace slowing. Cited 6,313 times.
| Year | Filings |
|---|---|
| 2014 | 13 |
| 2015 | 13 |
| 2016 | 13 |
| 2017 | 10 |
| 2018 | 15 |
| 2019 | 12 |
| 2020 | 10 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Investor mix
6 investors on record; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 33% |
| Private equity | 3 | 50% |
| Other / undisclosed | 1 | 17% |